Novartis and Generate:Biomedicines forge $1B AI drug discovery deal
Genetic Engineering & Biotechnology News (GEN) - 24-Sep-2024AI and biotech unite for next-gen protein drugs
Flagship Pioneering
Life sciences firm
We’re a leading life sciences firm that conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability.
Visit website: https://www.flagshippioneering.com/
Details last updated 30-Apr-2020
Flagship Pioneering News
Generate:Biomedicines raises $273m to drive AI-powered drug development
Pharmaceutical Technology - 15-Sep-2023New funding accelerates clinical trials and expands its pipeline of protein-based therapies
Laronde is creating safer and effective 'Endless RNA' therapies
Chemical & Engineering News (C&EN) - 30-Aug-2021Raised $440m to advance e-RNA based medicine for a wide range of diseases
Longevity Vision Fund joins Series B funding for Sigilon Therapeutics
Longevity Vision Fund - 20-Apr-2020To support human clinical trial of novel encapsulated cell therapy for hemophilia A
